Bilcare Management Change
BILCARE Limited disclosed a change in designation of two executive directors. Shreyans Mohan Bhandari is redesignated Executive Director, and Mohan Harakchand Bhandari moves to Non-Executive Non-Independent Director & CEO.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
BILCARE Limited disclosed a change in designation of two executive directors. Shreyans Mohan Bhandari is redesignated Executive Director, and Mohan Harakchand Bhandari moves to Non-Executive Non-Independent Director & CEO.
Bilcare Ltd reported revenue from operations of ₹248.4 Cr (+39.4% YoY) and net profit of ₹1.1 Cr for Q2 FY27.
Bilcare Limited scheduled a board meeting for 3 November 2026 to consider its unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The results have not yet been approved, so this is only a notice.
Bilcare Limited announced the dissolution of its wholly-owned subsidiary, Bilcare INC US, effective September 9, 2026. This action holds no material financial impact.
Bilcare Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing details shareholding distribution among promoters and the public.
Bilcare Limited issued a corrigendum for its 39th Annual General Meeting, correcting a clerical error where a director's appointment resolution was mislabeled as a special resolution.
Non-promoter Guttikonda Anuradha, Vara Lakshmi and Rajasekhar bought 4,73,264 Bilcare shares in the open market, lifting PAC holdings to 16.47%. No transaction price was disclosed.